Form 4 Tracker
Entrada Therapeutics, Inc.
TRDA

33 insider filings · Latest: Sep 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 9, 2026Sep 9 11:24 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
28,837$7.13$205.6K3,885,115(I)

View →

Sep 8, 2026Sep 9 11:24 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
192,500$7.41$1.4M3,913,952(I)

View →

Sep 4, 2026Sep 9 11:24 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
38,500$7.11$273.7K4,106,452(I)

View →

Sep 9, 2026Sep 9 11:23 PMMPM BioVentures 2014, L.P.10% Owner
Sale
28,837$7.13$205.6K3,885,115(I)

View →

Sep 8, 2026Sep 9 11:23 PMMPM BioVentures 2014, L.P.10% Owner
Sale
192,500$7.41$1.4M3,913,952(I)

View →

Sep 4, 2026Sep 9 11:23 PMMPM BioVentures 2014, L.P.10% Owner
Sale
38,500$7.11$273.7K4,106,452(I)

View →

Sep 3, 2026Sep 3 11:21 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
32,263$7.17$231.3K4,144,952(I)

View →

Sep 2, 2026Sep 3 11:21 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
25,131$7.19$180.7K4,177,215(I)

View →

Sep 1, 2026Sep 3 11:21 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
29,088$7.06$205.4K4,202,346(I)

View →

Sep 3, 2026Sep 3 11:21 PMMPM BioVentures 2014, L.P.10% Owner
Sale
32,263$7.17$231.3K4,144,952(I)

View →

Sep 2, 2026Sep 3 11:21 PMMPM BioVentures 2014, L.P.10% Owner
Sale
25,131$7.19$180.7K4,177,215(I)

View →

Sep 1, 2026Sep 3 11:21 PMMPM BioVentures 2014, L.P.10% Owner
Sale
29,088$7.06$205.4K4,202,346(I)

View →

Aug 31, 2026Aug 31 10:26 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
44,259$6.99$309.4K4,231,434(I)

View →

Aug 28, 2026Aug 31 10:26 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
3,733$7.01$26.2K4,275,693(I)

View →

Aug 27, 2026Aug 31 10:26 PMMPM BIOVENTURES 2018, L.P.10% Owner
Sale
38,922$7.20$280.2K4,279,426(I)

View →

Aug 31, 2026Aug 31 10:25 PMMPM BioVentures 2014, L.P.10% Owner
Sale
44,259$6.99$309.4K4,231,434(I)

View →

Aug 28, 2026Aug 31 10:25 PMMPM BioVentures 2014, L.P.10% Owner
Sale
3,733$7.01$26.2K4,275,693(I)

View →

Aug 27, 2026Aug 31 10:25 PMMPM BioVentures 2014, L.P.10% Owner
Sale
38,922$7.20$280.2K4,279,426(I)

View →

Aug 26, 2026Aug 27 1:28 AMMPM BioVentures 2014, L.P.10% Owner
Sale
14,569$7.06$102.9K4,318,348(I)

View →

Aug 25, 2026Aug 27 1:28 AMMPM BioVentures 2014, L.P.10% Owner
Sale
26,522$7.54$200.0K4,332,917(I)

View →

Page 1 of 4

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 10, 2026Jun 12 9:34 PMKush ParmarDirector, 10% Owner
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:17 PMPeter S KimDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:16 PMGina ChapmanDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:05 PMMaha RadhakrishnanDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 9:01 PMMary ThistleDirector
Grant/Award
19,000$5.9719,000(D)

View →

Jun 10, 2026Jun 12 8:52 PMBernhardt G ZeiherDirector
Grant/Award
19,000$5.9719,000(D)

View →

May 4, 2026May 4 11:24 PMNathan J DowdenPresident & COO
Option Exercise
15,000$1.7449,831(D)

View →

Mar 1, 2026Mar 3 11:21 PMDipal DoshiDirector, CEO
Grant/Award
208,000$11.93208,000(D)

View →

Mar 1, 2026Mar 3 11:20 PMKory James WentworthChief Financial Officer
Grant/Award
66,600$11.9366,600(D)

View →

Mar 1, 2026Mar 3 11:19 PMNathan J DowdenPresident & COO
Grant/Award
83,200$11.9383,200(D)

View →

Mar 1, 2026Mar 3 11:18 PMNatarajan SethuramanPresident, Research & Develop.
Grant/Award
83,200$11.9383,200(D)

View →